-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A666740 | Anti-Ang2 & VEGFA Reference Antibody (Faricimab), Target:Angiopoietin2&VEGF-A,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like Anti-Ang2 & VEGFA Reference Antibody (Faricimab), Target:Angiopoietin2&VEGF-A,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like |
|||
| A666728 | Anti-Ang2 & VEGFA Reference Antibody (Vanucizumab), Target:Angiopoietin2&VEGF,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like Anti-Ang2 & VEGFA Reference Antibody (Vanucizumab), Target:Angiopoietin2&VEGF,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like |
|||
| A998412 | Anti-ANGPT2 Reference Antibody (MEDI3617), Anti-ANGPT2 Reference Antibody (MEDI3617), |
|||
| A998413 | Anti-ANGPT2 Reference Antibody (nesvacumab), Anti-ANGPT2 Reference Antibody (nesvacumab), |
|||
| A998414 | Anti-ANGPT2 Reference Antibody (Roche patent anti-ANG-2), Anti-ANGPT2 Reference Antibody (Roche patent anti-ANG-2), |
|||
| A998415 | Anti-ANGPT2 Reference Antibody (zansecimab), Anti-ANGPT2 Reference Antibody (zansecimab), |
|||
| A998416 | Anti-ANGPTL3 Reference Antibody (evinacumab), Anti-ANGPTL3 Reference Antibody (evinacumab), |
|||
| A998417 | Anti-ANGPTL4 Reference Antibody (Nanyang Tech.U. patent anti-ANGPTL4), Anti-ANGPTL4 Reference Antibody (Nanyang Tech.U. patent anti-ANGPTL4), |
|||
| A998418 | Anti-ANGPTL8 Reference Antibody (Regeneron patent anti-ANGPTL8), Anti-ANGPTL8 Reference Antibody (Regeneron patent anti-ANGPTL8), |
|||
| A998419 | Anti-ANO1 / TMEM16A Reference Antibody (Novartis patent anti-TMEM16A ), Anti-ANO1 / TMEM16A Reference Antibody (Novartis patent anti-TMEM16A ), |
|||
| A998420 | Anti-AOC3 / VAP1 Reference Antibody (timolumab), Anti-AOC3 / VAP1 Reference Antibody (timolumab), |
|||
| A998421 | Anti-ASIC1 Reference Antibody (Regeneron patent anti-ASIC1), Anti-ASIC1 Reference Antibody (Regeneron patent anti-ASIC1), |
|||
| A998422 | Anti-AXL / UFO Reference Antibody (enapotamab), Anti-AXL / UFO Reference Antibody (enapotamab), |
|||
| A998423 | Anti-AXL / UFO Reference Antibody (mipasetamAb), Anti-AXL / UFO Reference Antibody (mipasetamAb), |
|||
| A998424 | Anti-AXL / UFO Reference Antibody (ORY012), Anti-AXL / UFO Reference Antibody (ORY012), |
|||
| A998425 | Anti-AXL / UFO Reference Antibody (tilvestamab), Anti-AXL / UFO Reference Antibody (tilvestamab), |
|||
| A998426 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (adebrelimab), Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (adebrelimab), |
|||
| A998427 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (atezolizumab), Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (atezolizumab), |
|||
| A998428 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab), Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab), |
|||
| A998429 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (cosibelimab), Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (cosibelimab), |
